MERILOG (insulin aspart-szjj)
MERILOG (insulin aspart-szjj) is a rapid-acting human insulin analog. It is indicated to improve glycemic control in both adult and pediatric patients diagnosed with diabetes mellitus. This medication serves as a therapeutic intervention for managing blood sugar levels in patients requiring insulin therapy.
How MERILOG Works
MERILOG regulates glucose metabolism by lowering blood glucose levels through the stimulation of peripheral glucose uptake in skeletal muscle and fat. It further controls blood sugar by inhibiting the production of glucose within the liver. Beyond glucose regulation, the drug inhibits the breakdown of fats and proteins while simultaneously enhancing protein synthesis.
Details
- Status
- Prescription
- First Approved
- 2025-02-14
- Routes
- SOLUTION
- Dosage Forms
- INJECTION
MERILOG Approval History
What MERILOG Treats
1 indicationsMERILOG is approved for 1 conditions since its original approval in 2025. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Diabetes
MERILOG is a lower-cost alternative to Fiasp with no clinically meaningful differences. Requires prescriber approval to substitute.
MERILOG Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Direct competitors
Same target(s) AND same indication — head-to-head.
MoA expansion candidates
Same target(s), different indications — where else is this mechanism being explored?
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in MERILOG's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications MERILOG treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to MERILOG
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MERILOG FDA Label Details
Indications & Usage
FDA Label (PDF)MERILOG is indicated for the treatment of Diabetes.
Track MERILOG with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.